Contenuto
Ti trovi in: HOME »Programmi, progetti e risultati »I progetti »PRIN - Programmi di ricerca di Rilevante Interesse Nazionale»Programma di ricercaINIZIO_TESTO_DA_INDICIZZARE
PROGRAMMA DI RICERCA 2006
italiano - english
Unità di Ricerca
- Università degli Studi di ROMA "Tor Vergata"
MEDICINA SPERIMENTALE E SCIENZE BIOCHIMICHE
- Università degli Studi di ROMA "Tor Vergata"
MEDICINA SPERIMENTALE E SCIENZE BIOCHIMICHE
- Università degli Studi di ROMA "Tor Vergata"
MEDICINA SPERIMENTALE E SCIENZE BIOCHIMICHE
- Università degli Studi di MESSINA
SCIENZE MICROBIOLOGICHE, GENETICHE E MOLECOLARI
Programmi di ricerca simili:
- 1 - Apoptosi ed Infezioni virali.
- 2 - RUOLO DEL VIRUS HERPES SIMPLEX-1 NELL'ATTIVAZIONE DI PATHWAY INTRACELLULARI COINVOLTI NELLA NEURODEGENERAZIONE: POSSIBILI IMPLICAZIONI NELLA PATOGENESI DELLA MALATTIA DI ALZHEIMER
- 3 - Infezioni virali persistenti, latenti e croniche da virus a DNA e ad RNA: studio dei meccanismi di regolazione genica e della risposta immune.
- 4 - Basi molecolari della penetrazione e della risposta dell'ospite alla infezione con herpesvirus umani
- 5 - RUOLO DELLE INFEZIONI DA HERPES SIMPLEX VIRUS -1 NELLA PATOGENESI DELLA MALATTIA DI ALZHEIMER
- 6 - Ruolo di fattori virali e cellulari nelle interazioni tra virus di Epstein-Barr e cellula ospite
- 7 - Genomica funzionale di Bovine herpesvirus type 4 (BoHV-4) sull'infezione/transduzione del sistema nervoso centrale del topo in vitro ed in vivo
- 8 - BERSAGLI MOLECOLARI PER NUOVE TERAPIE ANTINEOPLASTICHE ATTRAVERSO LO STUDIO DI PROTEINE-SEGNALE CELLULARI E VIRALI E DI INIBITORI SPECIFICI
- 9 - Fattori di virulenza e di resistenza nella patogenesi delle infezioni retrovirali
- 10 - Un approccio biomolecolare per la patologia HHV8-associata e la sua possibile trasformazione neoplastica:
Classificazione scientifico-disciplinare
- Area scientifico disciplinare: Scienze mediche
Classificazione brevettuale
- CHEMISTRY; METALLURGY
- BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
- BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Classificazione geografica
- Regione: Lazio
Bibliografia
1. Ameisen, J.C., Pleskoff, O., Lelievre, J.D. and De Bels, F. 2003. Subversion of cell survival and cell death: viruses as enemies, tools, teachers and allies. Cell Death Different. 10: S3-S6.2. Amini S, Mameli G, Del Valle L, Skowronska A, Reiss K, Gelman BB, White MK, Khalili K, Sawaya BE. 2005. p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28. Mol Cell Biol. 25:8126-8138.
3. Badley, A.D., Pilon, A.A., Landay, A., and Lynch, D.H.. 2000. Mechanisms of HIV-associated lymphocyte apoptosis. Blood. 96:2951-2964.
4. Barber, G.N. 2001. Host defense, viruses and apoptosis. Cell Death Differ. 8:113-126.
5. Benedict, C.A., Norris, P.S. and Ware, C.F. 2002. To kill or be killed: viral evasion of apoptosis. Nat. Immunol. 3: 1013-1018.
6. Borner, C. 2003. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. immunol. 39:615-647.
7. Boya, P., Roumier, T., Andreau, K., Gonzales-Polo, R., Zamzami, N., Castedo, M. and Kroemer, G. 2003. Mitochondrion-targeted apoptosis regulators of viral origin. Biochem.Biophysic.Res.Commun. 304: 575-581.
8. Brenner, C., and Kroemer, G. 2000. Apoptosis. Mitochondria - the death signal integrators. Science 289: 1150-1151.
9. Castedo, M., Ferri, K.F., Blanco, J., Roumier, T., Larochette, N., Barretina, J., Amendola, A., Nardacci, R., Metivier, D., Este, J.A., Piacentini, M., and Kroemer, G. 2001. Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosisinvolves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation.J Exp Med. 194:1097-1110.
10. Chen, W., Calvo, P.A., Malide, D., Gibbs, J., Schubert, U., Bacik, I., Basta, S., O'Neill, R., Schickli, J., Palese P., Henklein, P.,Bennink, J.R., and Yewdell, J.W. 2001. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7:
1306-1312.
11. Cory, S., D.C.S. Huang, and J.M. Adams. 2003. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 22:8590-8607.
12. De Laurenzi, V., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M. and Melino, G. 1998. Two new p73 splice variants, gamma and delta, with different transcriptional activity. J Exp Med 188: 1763-1768.
13. Dobbelstein, M., and Roth, J. 1998. The large T antigen of simian virus 40 binds and inactivates p53 but not p73. J. Gen Virol.79: 3079-3083.
14. Du, C., Fang, M., Li, Y., Li, L., Wang, X. 2000. Smac, a mitochondrial protein that promotes cytochrome-c dependent caspaseactivation by eliminating IAP inhibition. Cell 101: 33-42.
15. El-Deiry, W.S. 1998. Regulation of p53 downstream genes. Semin Cancer Biol 8: 345-357.
16. Flinterman M, Guelen L, Ezzati-Nik S, Killick R, Melino G, Tominaga K, Mymryk JS, Gaken J, Tavassoli M. 2005. E1A activates transcription of p73 and Noxa to induce apoptosis. J Biol Chem. 2005. 280:5945-5959.
17. Franchini, G., Nicot, C. and Johnson, J.M. 2003. Seizing of T cells by human T-cell leukaemia/lymphoma virus type 1. Adv.Cancer Res. 89: 69-132.
18. Goodkin, M.L., E.R. Morton, and J.A. Blaho. 2004. Herpes simplex virus infection and apoptosis. Int. Rev. Immunol. 23:141-172.
19. Gougeon, M.L, 2003. Apoptosis as an HIV strategy to escape immune attack. Nat. Rev. Immunol. 3: 392-404.
20. Hardwick, J.M., and D.S. Bellows. 2003. Viral versus cellular BCL-2 proteins. Cell Death Differ. 10:S68-S76.
21. Hay, S., and G. Kannourakis. 2002. A time to kill: viral manipulation of the cell death program. J. Gen. Virol. 83:1547-1564.
22. Higashino, F., Pipas, J.M., and Shenk, T. 1998. Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73. Proc. Natl. Acad. Sci. USA 95: 15683-15687.
23. Hollstein, M., Sidransky, D. and Vogelstein, C.C. 1991. p53 mutations in human cancers. Science 253: 49-53.
24. Ikawa, S., Nakagawara, A. and Ikawa, Y. 1999. p53 family genes: structural comparison, expression and mutation. Cell Death Differ. 6: 1154-1161.
25. Kerr, J.F.R., Wyllie, A.H., Currie, A.R. 1972. Apoptosis: a basic biological phenomenon with wide ranging implication in tissue kinetics. Br. J. Cancer 26: 239-257.
26. Kieff, E., and Shenk, T. 1998. Modulation of apoptosis by herpesviruses. Semin. Virol. 8: 471-480.
27. Ko, L.J. and Prives, C. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054-72.
28. Kroemer, G., and Reed, J.C. 2000. Mitochondrial control of cell death. Nature Med. 6: 513-519.
29. Marchenko, N.D., Zaika, A., and Moll, U.M. 2000. Death signal-induced localisation of p53 to mitochondria. A potential role in apoptosis signalling. J. Biol. Chem 275: 16202-16212.
30. Mastino, A., M.T. Sciortino, M.A. Medici, D. Perri, M.G. Ammendolia, S. Grelli, C. Amici, A. Pernice, and S. Guglielmino. 1997. Herpes simplex virus 2 causes apoptotic infection in monocytoid cells. Cell Death Differ. 4:629-638
31. Medici, M.A., M.T. Sciortino, D. Perri, C. Amici, E. Avitabile, M. Ciotti, E. Balestrieri, E. De Smaele, G. Franzoso, and A. Mastino. 2003. Protection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor kappa B. J. Biol. Chem. 278:36059-36067.
32. Nencioni, L., Iuvara, A., Aquilano, K., Circolo, M.R., Cozzolino, F., Rotilio, G., Garaci, E. and Palamara, A.T. 2003. Influenza A virus replication is dependent on an antioxidant pathway that involves GSH and Bcl-2. FASEB J. 17: 758-760.
33. Polster, B.M., J. Pevsner, and J.M. Hardwick. 2004. Viral Bcl-2 homologs and their role in virus replication and associated diseases. Bioch. Biophys. Acta. 1644:211-227.
34. Roulston, A., Marcellus, R.C. and Branton, P.E. 1999. Viruses and apoptosis. Annu. Rev. Microbiol. 53: 577-628.
35. Steengenga, W.T., Shvarts, A., Riteco, N., Bos, J.L., and Jochemsen, A.G. 1999. Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and E4orf6 proteins. Mol. Cell. Biol. 19: 3885-3894.
36. Thomson, B.J. 2001. Viruses and apoptosis. Int. J. Exp. Pathol. 82: 65-76.
37. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M.D., Dotsch, V., Andrews, N.C., Caput, D. and McKeon, F. 1998. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 2:305-316.
38. Zeng, X., Li, X., Miller, A., Yuan, Z., Yuan, W., Kwok, R.P., Goodman, R. and Lu, H. 2000. The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis. Mol. Cell. Biol. 20: 1299-1310.



